ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc (VNDA)

5.23
0.32
(6.52%)
Closed May 27 4:00PM
5.20
-0.03
(-0.57%)
After Hours: 7:49PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
5.20
Bid
5.10
Ask
5.20
Volume
896,861
4.91 Day's Range 5.23
3.295 52 Week Range 6.76
Market Cap
Previous Close
4.91
Open
4.95
Last Trade Time
Financial Volume
$ 4,597,688
VWAP
5.1264
Average Volume (3m)
2,485,621
Shares Outstanding
57,537,499
Dividend Yield
-
PE Ratio
119.72
Earnings Per Share (EPS)
0.04
Revenue
192.64M
Net Profit
2.51M

About Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder... Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Vanda Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VNDA. The last closing price for Vanda Pharmaceuticals was $4.91. Over the last year, Vanda Pharmaceuticals shares have traded in a share price range of $ 3.295 to $ 6.76.

Vanda Pharmaceuticals currently has 57,537,499 shares outstanding. The market capitalization of Vanda Pharmaceuticals is $300.35 million. Vanda Pharmaceuticals has a price to earnings ratio (PE ratio) of 119.72.

VNDA Latest News

Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders

Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders PR Newswire WASHINGTON, May 24...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.33-5.967450271255.535.694.88017585505.176647CS
40.6313.78555798694.575.954.4512193645.13358762CS
120.7316.33109619694.476.033.7124856214.88405861CS
261.748.57142857143.56.033.4616928594.60903018CS
52-1.09-17.32909379976.296.763.29513220094.74023067CS
156-13.42-72.073039742218.6221.86273.2957794937.79732798CS
260-10.45-66.773162939315.6521.86273.2957030059.64013869CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
AKANAkanda Corporation
$ 4.07
(70.29%)
39.11M
TKLFYoshitsu Company Ltd
$ 0.3496
(53.33%)
84.5M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M
MRUSMerus NV
$ 59.92
(35.97%)
6.91M
VSTMVerastem Inc
$ 4.0901
(-66.42%)
19.68M
TOIIWOncology Institute Inc
$ 0.0443
(-55.61%)
280.55k
SNSESensei Biotherapeutics Inc
$ 0.7912
(-45.43%)
1.41M
GNLXGenelux Corporation
$ 2.61
(-43.26%)
3.32M
AUVIApplied UV Inc
$ 0.32
(-33.33%)
5.18M
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
GWAVGreenwave Technology Solutions Inc
$ 0.0843
(-4.85%)
428.98M
NCPLNetcapital Inc
$ 0.20
(14.42%)
191.35M
HLTHCue Health Inc
$ 0.0931
(-1.27%)
160.21M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M

VNDA Discussion

View Posts
harry crumb harry crumb 2 weeks ago
Gonna be a winner. Patience
πŸ‘οΈ0
harry crumb harry crumb 3 weeks ago
Over 5$!
πŸ‘οΈ0
Monksdream Monksdream 3 weeks ago
VNDA under $5
πŸ‘οΈ0
harry crumb harry crumb 4 weeks ago
Let er rip $$$$$$$$
πŸ‘οΈ0
Tiger Money Tiger Money 1 month ago
Agreed. This could double quickly
πŸ‘οΈ0
philaya philaya 1 month ago
got this today...
very good trades.
πŸ‘οΈ0
harry crumb harry crumb 1 month ago
This little gem could run up fast, they obviously have their science going in the right direction as the offers are there just not the price, could be a 10.00 offer in the works
πŸ‘οΈ0
morokoy morokoy 1 month ago
Shares Outstanding 57,537,499 shares
Insider Shares 7,908,897 shares
Insider Ownership 13.75 %
Total Insiders 34
πŸ‘οΈ0
morokoy morokoy 1 month ago
"The dividend distribution of rights will be payable to stockholders of record as of the close of business on April 29, 2024."

A shareholder may also receive distributions such as additional stock or stock rights in the distributing corporation; such distributions may or may not qualify as dividends.

A shareholder may also receive distributions such as additional stock or stock rights in the distributing corporation; such distributions may or may not qualify as dividends. You should receive a Form 1099-DIV, Dividends and Distributions from each payer for distributions of at least $10.

Guess we'll have to wait on the promised 8K.

Additional details of the Rights Plan will be contained in a Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission (the "SEC"). The filing will be available on the SEC's website at www.sec.gov.
πŸ‘οΈ0
harry crumb harry crumb 1 month ago
Minimum 8$ imo
πŸ‘οΈ0
MiamiGent MiamiGent 1 month ago
Vanda Pharmaceuticals rejects takeover proposal from Future Pak
REUTERS
1 mins ago
April 17 (Reuters) - Vanda Pharmaceuticals Inc (VNDA.NaE) on Wednesday said it is rejecting a takeover proposal from Future Pak, a privately-held contract manufacturer and packager of pharmaceuticals, as it significantly undervalues the company.

(Reporting by Sriparna Roy in Bengaluru; Editing by Tasim Zahid)
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️ 1
MiamiGent MiamiGent 1 month ago
Probably...but I took it at 5.49
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
Will it grow legs after 9:30
πŸ‘οΈ0
MiamiGent MiamiGent 1 month ago
VNDA Vol picking up..

$5.49 +$1.44 (+35.56%)

Volume 3,354,569

90 DAV... 2M
πŸ‘οΈ0
MiamiGent MiamiGent 1 month ago
VNDA Here we go
$5.3781 +$1.3281 (32.79%)

Bid ARCX
5.36 x 10
Ask XNMS
5.38 x 11
Volume
2,971,106
πŸ‘οΈ0
MiamiGent MiamiGent 1 month ago
VNDA Vol is good. Already @ 90 DAV
Volume 2,056,421
10/90-day avg. volume
7M / 2M
πŸ‘οΈ0
MiamiGent MiamiGent 1 month ago
VNDA Good post, Laster.
https://www.futurepak.com/
πŸ‘οΈ0
Laster Laster 1 month ago
The major question is who is Future Pak really?
Is this a legit offer?
Either way, company is extremely undervalued with no debt (I believe) and lots of cash.
Large short position. Lots of selling PM at $5.
Market does not seem to believe this offer. Sorry.
πŸ‘οΈ0
MiamiGent MiamiGent 1 month ago
VNDA Float 52.05M

Shares Short (3/28/2024) 2.49M
Short Ratio (3/28/2024) 2.78
Short % of Float (3/28/2024) 5.45%
πŸ‘οΈ0
MiamiGent MiamiGent 1 month ago
VNDA
Bid EDGX
4.85 x 3
Ask EDGX
4.88 x 3

Volume
1,790,654
Avg Vol (10 day) 6.63M
πŸ‘οΈ0
MiamiGent MiamiGent 1 month ago
Vanda Pharmaceuticals
Closed .01 (-0.25%)

Pre-market
$5.15 +1.10 (+27.16%)
As of Apr-17-2024 7:23:52 AM ET
Bid x size $5.14 x 1
Ask x size $5.16 x 3
πŸ‘οΈ0
MiamiGent MiamiGent 1 month ago
VNDA In 5.12. Let's see, said the blind man.
πŸ‘οΈ0
MiamiGent MiamiGent 1 month ago
Vanda Pharmaceuticals jumps 38% on Future Pak's latest buy offer
Apr. 17, 2024 6:41 AM ETVanda Pharmaceuticals Inc. (VNDA) Stock
πŸ‘οΈ0
MiamiGent MiamiGent 1 month ago
What's the news?
πŸ‘οΈ0
Awl416 Awl416 1 month ago
Damn
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
Will it grow legs after 9:30
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
Will it grow legs after 9:30
πŸ‘οΈ0
tknuncle tknuncle 4 months ago
I have been acquiring since $3.90. I wish that I would have waited longer lol but, like what I see with VNDA. Was going to grab the last of my starter position soon. GLTA
πŸ‘οΈ0
weedtrader420 weedtrader420 4 months ago
FDA Approve
πŸ‘οΈ0
Triple nickle Triple nickle 6 months ago
Fda accepts new drug application for tradipitant in the after hours today
👍️ 1
jgrabar jgrabar 2 years ago
$VNDA -On May 19, 2022, Vanda Pharmaceuticals agreed to settle a securities fraud class action complaint (the β€œComplaint”) for $11.5 Million. https://grabarlaw.com/the-latest/vanda-pharmaceuticals-investigation/
πŸ‘οΈ0
RNsidersbuying RNsidersbuying 3 years ago
VNDA 12.34 - FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome

https://ih.advfn.com/stock-market/NASDAQ/vanda-pharmaceuticals-VNDA/stock-news/83807075/fda-approves-hetlioz-tasimelteon-for-the-treatmen
πŸ‘οΈ0
XenaLives XenaLives 4 years ago
Everything would be a lot better if the govt. would just let doctors treat COVID like another flu bug. The drama is getting old.
πŸ‘οΈ0
Peepson Peepson 4 years ago
Yo, this thing is going to trade sideways for a while. They have a drug that could help with covid but so does every other pharma company. Its a safe hold imo but nothing will happen fast i don't think
πŸ‘οΈ0
XenaLives XenaLives 4 years ago
What's up? Doesn't seem to be much interest. I was looking at the chart but haven't found much on the company yet.

πŸ‘οΈ0
otcmoneydoubler otcmoneydoubler 4 years ago
LOL. VNDA GOT NEWS TODAY. SO WHAT DD HAVE YOU GOT TO SHARE?
πŸ‘οΈ0
Peepson Peepson 4 years ago
Yo, does anyone still follow this board. I might have some interesting dd to share.
πŸ‘οΈ0
bezen bezen 7 years ago
https://finance.yahoo.com/news/jefferies-5-top-biotech-stocks-133534894.html
πŸ‘οΈ0
Coz Mabluda Coz Mabluda 8 years ago
Brett Jensen. SA article re VNDA. Expects positive analyst's review.

Vanda Pharmaceuticals (NASDAQ:VNDA) posted solid third quarter results on Thursday. Instead of losing a dime a share as expected, the company posted a profit of 11 cents a share. Revenue was also up more than 35% from the same period a year ago. The company now looks like it could be profitable in FY2017. I expect some positive analyst commentary on this name by analysts over the next week. Vanda has a solid pipeline and over $140 million in cash and marketable securities on the balance sheet. One has to like the company's growth trajectory and the concern seems undervalued with just a $600 million market capitalization.



πŸ‘οΈ0
stocktrademan stocktrademan 8 years ago
fast and steady profit scan VNDA bullish 16.64



normal chart


log chart

πŸ‘οΈ0
ClearlyStocks ClearlyStocks 8 years ago
VNDA $16.74
πŸ‘οΈ0
ClearlyStocks ClearlyStocks 8 years ago
$VNDA $16 from $14 now
πŸ‘οΈ0
nyctraydr nyctraydr 8 years ago
Where Things Stand For Vanda Pharmaceuticals In Fanapt Patent Suit http://marketexclusive.com/things-stand-vanda-pharmaceuticals-inc-nasdaqvnda-fanapt-patent-suit/24951/?icd1
πŸ‘οΈ0
ClayTrader ClayTrader 8 years ago
* * $VNDA Video Chart 08-25-16 * *

Link to Video - click here to watch the technical chart video
πŸ‘οΈ0
ClearlyStocks ClearlyStocks 8 years ago
$15.24 weeee
πŸ‘οΈ0
ClearlyStocks ClearlyStocks 8 years ago
$14.60
πŸ‘οΈ0
ClearlyStocks ClearlyStocks 8 years ago
$14.22
πŸ‘οΈ0
ClearlyStocks ClearlyStocks 8 years ago
$14 wow
πŸ‘οΈ0
GREEN MAKER GREEN MAKER 8 years ago
Approved!!!!!
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock